alexa Ruptured Mycotic Aortic Aneurysm Secondary to Escherichia Coli Bacteremia in an HIV-Positive Patient | Open Access Journals
ISSN: 2165-7920
Journal of Clinical Case Reports
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Ruptured Mycotic Aortic Aneurysm Secondary to Escherichia Coli Bacteremia in an HIV-Positive Patient

Nicholas David Ward and Jean Marie Ruddy*

Department of Surgery, Medical University of South Carolina, USA

*Corresponding Author:
Jean Marie Ruddy
Department of Surgery
Medical University of South Carolina, USA
Tel: 8438764855
E-mail: ruddy@musc.edu

Received Date: March 03, 2017; Accepted Date: March 22, 2017; Published Date: March 27, 2017

Citation:Ward ND, Ruddy JM (2017) Ruptured Mycotic Aortic Aneurysm Secondary to Escherichia coli Bacteremia in an HIV-Positive Patient. J Clin Case Rep 7:941. doi: 10.4172/2165-7920.1000941

Copyright: © 2017 Ward ND, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical Case Reports

Abstract

Mycotic aortic aneurysms are an aggressive form of degenerative remodeling reported more commonly in immunosuppressed patients. These aneurysms carry a high risk of progression to rupture, fulminant sepsis, and death, and therefore require prompt operative intervention. The human immunodeficiency virus (HIV) has also been associated with a broad spectrum of vascular disease, including development of aneurysms, however these have typically been identified in the peripheral vasculature. We report the case of a 71-year-old, HIV-positive male who presented with Escherichia coli bacteremia and aortitis which rapidly progressed to a ruptured infrarenal mycotic aortic aneurysm. He was managed successfully with open debridement and in situ implantation of a rifampin-soaked prosthetic graft as well as long-term antibiotic therapy. Here, we review the epidemiology, pathophysiology, and optimal surgical treatment of mycotic aortic aneurysms.

Keywords

Aortic aneurysms; Epidemiology; Escherichia coli

Introduction

HIV-related vasculopathy comprises a broad spectrum of disease, including occlusive disease, aneurysm formation, and microangiopathy [1,2]. HIV-related aneurysmal disease has been shown to be a distinct pathologic entity from atherosclerotic and mycotic aneurysms [3] and can be distinguished by several features-the presence of multiple aneurysms in atypical locations, younger patient age, fewer traditional atherosclerotic risk factors, and unique histopathology defined by peri-adventitial inflammatory infiltrates [4-8]. It remains unclear to what extent direct viral action versus opportunistic bacterial infection is responsible [2]. Mycotic aortic aneurysms (MAA) are also a rare and highly morbid subset of abdominal aortic aneurysms (AAA), comprising only 0.7% to 1.8% of all AAA [4,5]. Management of MAA has been a challenging problem for the vascular surgeon, as it often presents late in the course of disease in immunocompromised hosts and carries a high risk of progression to rupture, fulminant sepsis, and death [4,5]. MAA traditionally mandates operative intervention in the form of in situ graft placement or extra-anatomic bypass followed by aortic debridement and ligation, though successful endovascular management has recently been described for non-ruptured MAA [6,7] Commonly implicated organisms include Staphylococcus and Salmonella species, with Escherichia coli less frequently identified [4,8]. In the HIV-infected population, MAA secondary to opportunistic pathogens have also been reported [9,10]. and this report focuses on an unusual case of rapidly progressive, ruptured MAA in an HIV-positive patient successfully managed with in situ prosthetic reconstruction.

Case Report

A 71 year-old male with past medical history significant for hypertension, HIV, benign prostatic hypertrophy, and tobacco abuse presented to a community hospital complaining of several weeks of escalating back pain. The patient’s HIV has been well-controlled on HAART therapy with Genvoya (Elvitegravir, Cobicistat, Emticitabine, Tenofovir Alafenamide), with recent CD4 count of 524/mm3 and an undetectable viral load. On physical exam, he had mild abdominal and flank tenderness as well as palpable femoral pulses. Following surgical consultation, a CT scan of the abdomen and pelvis was performed which revealed penetrating aortic ulcers of the infrarenal aorta and significant peri-aortic stranding consistent with aortitis. Maximal aortic diameter was 2.5 cm (Figure 1a). He was managed non-operatively with broad-spectrum antibiotics, and de-escalated to ceftriaxone after E. coli was isolated from blood cultures on the second day of admission. Repeat blood cultures after 48 hours of antibiotic therapy were negative, suggesting clearance of the patient’s bacteremia. On hospital day nine, however, the patient developed acute worsening of his back pain. A repeat CT aortogram of the abdomen and pelvis revealed progression of the penetrating aortic ulcer to a saccular mycotic aortic aneurysm with extraluminal contrast consistent with contained rupture (Figure 1b). The patient remained hemodynamically stable, and was subsequently transferred to the Medical University of South Carolina Aortic Center.

clinical-case-reports-Coronal-CT

Figure 1: Coronal CT projections demonstrating (A) penetrating aortic ulcer with peri-aortic stranding consistent with infrarenal aortitis, and (B) rapid progression to mycotic aortic aneurysm with contained rupture.

Upon the patient’s arrival, impulse control was initiated with nicardipine and Esmolol infusions, with goal heart rate <70 beats per minute and goal systolic blood pressure <130 mmHg. His white blood cell count was within normal limits at this time. He was taken emergently to the operating room for open repair through a midline laparotomy. The supraceliac aorta was exposed for emergency control as needed and the infrarenal aorta was approached near the bifurcation. Dense periaortic inflammation was encountered which had distorted the ureteral anatomy and was accompanied by caseating granulomatous changes in the nearby lymph nodes. The left and right common iliac segments were cleared for clamp placement and following careful mobilization of the left ureter and duodenum, the inferior mesenteric artery was controlled. Moving proximally, it was clear that the densely inflamed and adherent left renal vein could not be salvaged. Additional dissection established space for clamp placement below the bilateral renal arteries, and following systemic heparinization, the infrarenal aorta was clamped. The aortotomy was extended from the bifurcation cranially through the left renal vein and this ligation was buttressed with nearby inflammatory tissue. Patent lumbar arteries were oversewn and the aortic wall was resected as able. More specifically, the region of rupture was debrided, including evacuation of retroperitoneal thrombus, and the cavity was thoroughly irrigated with antibiotic solution. Tissue culture was sent from this region. An interposition graft was then performed using a rifampin-soaked 14 mm × 7 mm Hemashield bifurcated graft (Maquet, Rastatt, Germany). Given the healthy appearance of the tissue at the bifurcation, the limbs were trimmed, effectively creating a tube graft. The proximal and distal anastomoses were created using 3-0 prolene suture in circumferential running fashion, and an omental flap was created and fastened into place over the graft with running 2-0 vicryl suture. Given patent hypogastric arteries bilaterally and the presence of brisk backbleeding from the inferior mesenteric artery, it was not re-implanted. The abdomen was irrigated with antibiotic solution and closed.

The patient’s post-operative course was complicated by acute kidney injury secondary to contrast nephropathy, but this returned to baseline by post-operative day 4 and the remainder of his recovery was uneventful. HAART therapy was maintained throughout his hospitalization and an emphasis was placed on post-operative nutrition. Intra-operative tissue culture was positive for pan-sensitive E. coli, and the patient was maintained on a six-week course of IV ceftriaxone with plans for longterm oral suppression therapy per the infectious disease specialists. He was discharged to a rehabilitation facility on post-operative day ten.

Discussion

Mycotic aneurysms may affect any artery, with the aorta, peripheral arteries, cerebral vessels, and visceral arteries affected in descending order of frequency [11,12]. Mycotic aortic aneurysms (MAA) comprise only a small minority of aortic aneurysms [4,5] and have been associated with an aggressive course with rapid progression. A large contemporary series of MAA have reported a high frequency of rupture at the time of presentation, ranging from 38% to 85% [4,6,8] with in-hospital mortality as high as 36% to 40% [5,13]. Causative organisms most frequently include Salmonella species and Staphylococcus aureus, with Streptococcus species and E. coli identified less commonly.4,8 In the majority of patients, at least one comorbid condition causing immunosuppression can be identified, including diabetes mellitus, steroid use, and chronic renal failure [4]. Additionally, it has been reported that nearly half of all patients presenting with MAA had a recent infection, including pneumonia, cholecystitis, urinary tract infection, endocarditis, and diverticulitis [4,5] MAA have also been described in the HIV-positive population in association with opportunistic pathogens, such as Mycobacterium avium and Listeria monocytogenes [9,10].

HIV-related vasculopathy comprises a broad spectrum of disease, including retinopathy, microangiopathic glomerular disease, occlusive disease, and aneurysm formation. HIV-related aneurysms often occur in multiple and atypical locations, preferentially affecting the carotid and superficial femoral arteries [1,3,14]. Typical histologic features include leukocytoclastic vasculitis of the vasa vasora and periadventitial vessels, chronic inflammation, and medial fibrosis with loss of elastic and muscular tissue [3,15]. While the etiology of HIV-related aneurysms remains unclear, it has been hypothesized that immunosuppression in HIV-positive patients makes them more susceptible to bacteremia and secondary mycotic aneurysm formation [1,2]. In this case, it has been suspected that the patient’s back and flank pain reflected underlying urinary tract infection, subsequently leading to bacteremia and seeding of the aorta with progression to MAA.

Given the high risk of morbidity and mortality, as evidenced by this patient’s progression to rupture in a matter of days, prompt operative intervention with debridement of infected aortic tissue is considered critical to management of MAA. Potential operative approaches include aortic ligation with extra-anatomic bypass, in situ reconstruction, and endovascular repair. Traditionally, aortic ligation with extra-anatomic bypass, such as axillary-femoral bypass grafting, has been advocated in cases of infrarenal aneurysms to avoid late infective complications [5,16]. Unfortunately, extra-anatomic bypass has been associated with higher rates of peri-operative complications and decreased long-term patency.8 Previous studies, for example, have reported a 20% risk of aortic stump disruption, a 20% to 29% amputation rate, and a 20% risk of reinfection [4,17]. In situ graft reconstruction, on the other hand, has been shown in multiple studies to be a safe and durable option, with no significant difference in graft-related complications or long-term survival [4,16,18]. To further reduce the risk of infection, most authors recommend use of a rifampin-soaked graft and buttressing of repair with an omental flap, if technically feasible [5,19]. Alternatively, recent studies have demonstrated the safety, efficacy, and feasibility of endovascular management of MAA, which has been shown to offer improved shortterm survival relative to open surgery without an increased incidence of infectious complications or need for reoperation [7]. However, in cases of MAA with rupture at the time of presentation, most authors continue to recommend open surgical management [6]. As the vascular surgeon’s armamentarium expands, thoughtful consideration of individual patient factors will be critical to improving outcomes and providing the best care possible.

Conclusion

Aortic aneurysm formation in HIV-infected patients may be due to a viral-induced angiopathy but bacterial infection may also contribute in the immunocompromised host. Mycotic aortic aneurysms typically have an aggressive and highly morbid course; therefore a high index of suspicion is critical to ensure timely diagnosis and prompt surgical intervention.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • Global Experts meeting on Oncology Case Reports
    Aug 29-31, 2017 London, UK
  • Global Experts Meeting on Case Reports
    Osaka, Japan October 09-11, 2017
  • 6th Global Experts Meeting on Medical Case Reports
    October 16-18, 2017 San Francisco, California, USA

Article Usage

  • Total views: 85
  • [From(publication date):
    March-2017 - May 25, 2017]
  • Breakdown by view type
  • HTML page views : 66
  • PDF downloads :19
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version